Methicillin-resistant strains of Staphylococcus aureus: Presence of identical additional penicillin-binding protein in all strains examined FEMS microbiology letters, 33 (1986) 251–254 P.E. Reynolds and C. Fuller

1986 ◽  
Vol 34 (3) ◽  
pp. 367
2016 ◽  
Vol 60 (7) ◽  
pp. 3934-3941 ◽  
Author(s):  
Liana C. Chan ◽  
Aubre Gilbert ◽  
Li Basuino ◽  
Thaina M. da Costa ◽  
Stephanie M. Hamilton ◽  
...  

ABSTRACTStaphylococcus aureusis an important cause of both hospital- and community-associated methicillin-resistantS. aureus(MRSA) infections worldwide. β-Lactam antibiotics are the drugs of choice to treatS. aureusinfections, but resistance to these and other antibiotics make treatment problematic. High-level β-lactam resistance ofS. aureushas always been attributed to the horizontally acquired penicillin binding protein 2a (PBP 2a) encoded by themecAgene. Here, we show thatS. aureuscan also express high-level resistance to β-lactams, including new-generation broad-spectrum cephalosporins that are active against methicillin-resistant strains, through an uncanonical core genome-encoded penicillin binding protein, PBP 4, a nonessential enzyme previously considered not to be important for staphylococcal β-lactam resistance. Our results show that PBP 4 can mediate high-level resistance to β-lactams.


2013 ◽  
Vol 57 (10) ◽  
pp. 5005-5012 ◽  
Author(s):  
Andrew D. Berti ◽  
George Sakoulas ◽  
Victor Nizet ◽  
Ryan Tewhey ◽  
Warren E. Rose

ABSTRACTThe activity of daptomycin (DAP) against methicillin-resistantStaphylococcus aureus(MRSA) is enhanced in the presence of subinhibitory concentrations of antistaphylococcal β-lactam antibiotics by an undefined mechanism. Given the variability in the penicillin-binding protein (PBP)-binding profiles of different β-lactam antibiotics, the purpose of this study was to examine the relative enhancement of DAP activity against MRSA by different β-lactam antibiotics to determine if a specific PBP-binding profile is associated with the ability to enhance the anti-MRSA activity of DAP. We determined that both broad- and narrow-spectrum β-lactam antibiotics known to exhibit PBP1 binding demonstrated potent enhancement of DAP anti-MRSA activity, whereas β-lactam antibiotics with minimal PBP1 binding (cefoxitin, ceftriaxone, cefaclor, and cefotaxime) were less effective. We suspect that PBP1 disruption by β-lactam antibiotics affects pathways of cell division inS. aureusthat may be a compensatory response to DAP membrane insertion, resulting in DAP hypersusceptibility.


Chemotherapy ◽  
1995 ◽  
Vol 41 (3) ◽  
pp. 172-177 ◽  
Author(s):  
Y. Sumita ◽  
M. Fukasawa ◽  
S. Mitsuhashi ◽  
M. Inoue

2018 ◽  
Vol 62 (7) ◽  
pp. e00091-18 ◽  
Author(s):  
M. Angeles Argudín ◽  
S. Roisin ◽  
L. Nienhaus ◽  
M. Dodémont ◽  
R. de Mendonça ◽  
...  

ABSTRACTMethicillin-resistantStaphylococcus aureusisolates lackingmecgenes (n= 32), collected from Belgian hospitals, were characterized for their β-lactamase production and the presence of mutations inpbpgenes, thepbp4promoter, and genes involved in penicillin-binding protein 4 overproduction (gdpPandyjbH). Twelve isolates were β-lactamase hyperproducers (BHPs), while 12 non-BHP isolates might produce an incomplete GdpP protein. Most isolates showed nucleotide missense mutations inpbpgenes. A few isolates also showed mutations in thepbp4promoter.


Sign in / Sign up

Export Citation Format

Share Document